# Optimizing adaptive cancer therapy: dynamic programming and evolutionary   game theory

**Authors:** Mark Gluzman, Jacob G. Scott, Alexander Vladimirsky

arXiv: 1812.01805 · 2020-08-06

## TL;DR

This paper develops a systematic method using dynamic programming and evolutionary game theory to optimize adaptive cancer therapy, aiming to reduce drug usage and improve recovery rates compared to standard treatments.

## Contribution

It introduces a novel framework combining dynamic programming and evolutionary game theory to optimize adaptive cancer treatment policies systematically.

## Key findings

- Optimal strategies significantly reduce drug usage.
- Adaptive policies increase likelihood of tumor recovery.
- Trade-offs between drug amount and recovery time are characterized.

## Abstract

Recent clinical trials have shown that the adaptive drug therapy can be more efficient than a standard MTD-based policy in treatment of cancer patients. The adaptive therapy paradigm is not based on a preset schedule; instead, the doses are administered based on the current state of tumor. But the adaptive treatment policies examined so far have been largely ad hoc. In this paper we propose a method for systematically optimizing the rules of adaptive policies based on an Evolutionary Game Theory model of cancer dynamics. Given a set of treatment objectives, we use the framework of dynamic programming to find the optimal treatment strategies. In particular, we optimize the total drug usage and time to recovery by solving a Hamilton-Jacobi-Bellman equation based on a mathematical model of tumor evolution. We compare adaptive/optimal treatment strategy with MTD-based treatment policy. We show that optimal treatment strategies can dramatically decrease the total amount of drugs prescribed as well as increase the fraction of initial tumour states from which the recovery is possible. We also examine the optimization trade-offs between the total administered drugs and recovery time. The adaptive therapy combined with optimal control theory is a promising concept in the cancer treatment and should be integrated into clinical trial design.

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/1812.01805/full.md

## Figures

35 figures with captions in the complete paper: https://tomesphere.com/paper/1812.01805/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/1812.01805/full.md

---
Source: https://tomesphere.com/paper/1812.01805